Medical business management service provider Medac Inc. has completed a Service Organization Control 2 certification. Read More »

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies. Read More »

Newly released data published in the Multiple Sclerosis Journal shows Cladribine tablets significantly reduce brain atrophy in patients suffering with multiple sclerosis. Read More »

Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City. Read More »

Biotech company Amgen submitted an application to the U.S. Food and Drug Administration for Blincyto, a drug used in the treatment of lymphoblastic leukemia, to broaden its uses and treatments. Read More »

The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes.  Read More »

The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities.  Read More »

The Centers for Disease Control and Prevention has releases detailed information on the risks that flu season presents.  Read More »

Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »

The European Commission has granted Eli Lilly & Co. marketing rights for Olumiant, a drug used to treat patients suffering with severe rheumatoid arthritis. Read More »

Cumberland Pharmaceuticals Inc.'s recent clinical study showed its Caldolor Injection (ibuprofen) to be a safe and effective source of fever reduction in hospitalized pediatric use. Read More »

AbbVie, a global biopharmaceutical company focused on research, will take part in the upcoming Cowen and Company 37th Annual Health Care Conference.  Read More »

CBI's Formulary, Co-Pay and Access Summit will convene April 11-12 to address patient affordability barriers and more.  Read More »

GlaxoSmithKline was awarded damages, fees and interest on Jan. 31 as arbitration concluded with Pernix Therapeutics Holdings Inc.  Read More »

The Association for Accessible Medicines (AAM) recently announced that its president and CEO, Chip Davis, made a statement regarding the confirmation of Tom Price as Secretary of Health and Human Services. Read More »

Dr. Bernie Zeiher, president of development at Astellas Pharma, recently addressed the use of biomarkers in the development of precise and specific treatments for patients.  Read More »

Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »

Purdue Pharma LP has named Margaret Feltz vice president and chief ethics/compliance officer, reporting to President and CEO Mark Timney. Read More »

Takeda Pharmaceuticals U.S.A. Inc. recently welcomed Catherine Pugh, the mayor of Baltimore, to its Chicago office to celebrate Black History Month. Read More »

Sandoz, a Novartis Division, recently announced plans to double sales in Japan over the 2015 to 2022 period as part of a grander, longterm strategy to deliver better access to high quality medicines to the nation. Read More »